Top Markets
Coin of the day
Lysogene S.A. Lysogene S.A.

Lysogene S.A.

LYS
Rankning i aktier #36618
Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy,... Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy, dedicated to discovering and advancing treatments for children affected by severe neurodegenerative lysosomal storage disorders. Its development pipeline includes LYS-SAF302, which is currently undergoing Phase II/III clinical trials for mucopolysaccharidosis type IIIA (MPS IIIA). Another promising candidate, LYS-GM101, is in Phase I/II development, targeting GM1 gangliosidosis. The company has also forged a research alliance with the Weizmann Institute of Science to pioneer novel adeno-associated virus (AAV) gene therapy approaches for conditions such as neuronopathic Gaucher disease, Parkinson's disease, and other related illnesses. Lysogene S.A. was established in 2009 and is headquartered in Neuilly-sur-Seine, France.
Aktiekurs
$0.30221445
Senast synkroniserad: 2023-05-22
Marknadsvärde
$2.49M
Förändring (1 dag)
-0.10%
Förändring (1 år)
0.00%
Land
FR
Handel Lysogene S.A. (LYS)

Kategori

Historik för aktiesplit för Lysogene S.A. (LYS)
Aktien Lysogene S.A. (symbol: LYS) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 15, 2026.
En LYS-aktie köpt före Aug 15, 2026 motsvarar nu 0 LYS-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE